Thus, our results suggest that FMT improves cardiac functions in T1D mice by reducing LAT1-driven increase in BCAA and down-regulating the mTOR/Bax/Bcl-2/caspase-3 pathway. This evidence concerns the gene CASP3 and type 1 diabetes mellitus.